» Authors » R Kirchmair

R Kirchmair

Explore the profile of R Kirchmair including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 463
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, et al.
Leukemia . 2017 Aug; 31(11):2388-2397. PMID: 28757617
The BCR/ABL1 inhibitor Nilotinib is increasingly used to treat patients with chronic myeloid leukemia (CML). Although otherwise well-tolerated, Nilotinib has been associated with the occurrence of progressive arterial occlusive disease...
2.
Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch J, et al.
Atherosclerosis . 2009 Feb; 206(1):265-9. PMID: 19237157
Aims: Vascular endothelial growth factor (VEGF) is a potent hypoxia-regulated angiogenic factor. Its soluble receptor soluble (s)Flt-1 binds VEGF with high affinity inhibiting the angiogenic function of VEGF. The role...
3.
Kaser S, Foger B, Ebenbichler C, Kirchmair R, Gander R, Ritsch A, et al.
Int J Obes Relat Metab Disord . 2001 Dec; 25(11):1633-9. PMID: 11753583
Aim: Phospholipid transfer protein (PLTP) and cholesteryl ester transfer protein (CETP) are key enzymes in lipoprotein metabolism facilitating the transfer and exchange of cholesteryl esters, triglycerides and phospholipids between lipoproteins....
4.
Gaenzer H, Sturm W, Neumayr G, Kirchmair R, Ebenbichler C, Ritsch A, et al.
Cardiovasc Res . 2001 Dec; 52(3):509-16. PMID: 11738068
Objective: Pronounced postprandial lipemia has been established as a risk factor for cardiovascular disease, but reports regarding its effect on endothelial function have been controversial. In the present study the...
5.
Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch J
J Am Coll Cardiol . 2001 Nov; 38(5):1313-9. PMID: 11691501
Objectives: We sought to analyze diameter changes of conduit arteries in response to whole-body exercise and hypothesized that this response might be endothelium-dependent and, therefore, impaired in smokers. Background: Hyperemia...
6.
Gaenzer H, Sturm W, Kirchmair R, Neumayr G, Ritsch A, Patsch J
Atherosclerosis . 2000 May; 149(1):227-8. PMID: 10799018
No abstract available.
7.
Kirchmair R, Sturm W, GANZER H, Patsch J
Wien Med Wochenschr . 1999 Jul; 149(5-6):139-43. PMID: 10408005
Several placebo-controlled prospective multicenter trials showed convincing evidence that cholesterol lowering with statins reduced mortality due to coronary heart disease. Subgroup analyses of diabetic patients demonstrated significant reduction of coronary...
8.
Kirchmair R, Allerberger F, Bangerl I, Egger C, Nachbaur K, Patsch J, et al.
Dig Dis Sci . 1998 May; 43(5):1129-32. PMID: 9590432
No abstract available.
9.
Eder U, LEITNER B, Kirchmair R, Pohl P, Jobst K, Smith A, et al.
J Neural Transm (Vienna) . 1998 May; 105(1):39-51. PMID: 9588759
Human cerebrospinal fluid (CSF) contains chromogranin A and B and secretogranin II which represent peptides secreted from neuronal large dense core vesicles. Within these vesicles these precursor peptides are at...
10.
Egger C, Kreczy A, Kirchmair R, Waldenberger P, Jaschke W, Vogel W
Am J Gastroenterol . 1997 Dec; 92(12):2292-4. PMID: 9399773
Gastric antral vascular ectasia, or "watermelon stomach," is a distinct clinical entity within the spectrum of upper gastrointestinal mucosal vascular abnormalities. The pathobiology of the disease is unclear. We here...